U.S. flag

An official website of the United States government

NM_004999.4(MYO6):c.1674+13A>G AND not specified

Germline classification:
Benign (1 submission)
Last evaluated:
May 7, 2012
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000155377.4

Allele description [Variation Report for NM_004999.4(MYO6):c.1674+13A>G]

NM_004999.4(MYO6):c.1674+13A>G

Gene:
MYO6:myosin VI [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6q14.1
Genomic location:
Preferred name:
NM_004999.4(MYO6):c.1674+13A>G
HGVS:
  • NC_000006.12:g.75862736A>G
  • NG_009934.2:g.118544A>G
  • NM_001300899.2:c.1674+13A>G
  • NM_001368136.1:c.1674+13A>G
  • NM_001368137.1:c.1674+13A>G
  • NM_001368138.1:c.1659+13A>G
  • NM_001368865.1:c.1674+13A>G
  • NM_001368866.1:c.1674+13A>G
  • NM_004999.4:c.1674+13A>GMANE SELECT
  • LRG_438t1:c.1674+13A>G
  • LRG_438:g.118544A>G
  • NC_000006.11:g.76572453A>G
  • NG_009934.1:g.118545A>G
  • NM_004999.3:c.1674+13A>G
Links:
dbSNP: rs6925845
NCBI 1000 Genomes Browser:
rs6925845
Molecular consequence:
  • NM_001300899.2:c.1674+13A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001368136.1:c.1674+13A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001368137.1:c.1674+13A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001368138.1:c.1659+13A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001368865.1:c.1674+13A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001368866.1:c.1674+13A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_004999.4:c.1674+13A>G - intron variant - [Sequence Ontology: SO:0001627]
Observations:
4

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000205064Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Benign
(May 7, 2012)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided44not providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000205064.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided4not providednot providedclinical testing PubMed (1)

Description

1674+13A>G in Intron 16 of MYO6: This variant is not expected to have clinical s ignificance because it is not located within the conserved splice consensus sequ ence and has been identified in 1.5% (55/3738) of African American chromosomes f rom a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.wash ington.edu/EVS; dbSNP rs6925845).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided4not provided4not provided

Last Updated: Feb 28, 2024